EUVIMEDEUVIMED entdecken
Crossref

Efficacy, Mechanism, and Structure–Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis

Zi-Ying Zhou, Lian-Qi Sun, Xiao-Yang Han, Yong-Jian Wang, Zhuo-Song Xie, Si-Tu Xue, Zhuo-Rong Li iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Zi-Ying Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Hauptthemen laut MEDLINE: Osteoporosis, Benzofurans. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most patients with senile osteoporosis (SOP) are severely deficient in bone mass, and treatments using bone resorption inhibitors, such as bisphosphonates, have shown limited efficacy. Small-molecule osteogenesis-promoting drugs are required to improve the treatment for this disease. Previously, we demonstrated that a compound with a benzofuran-like structure promoted bone formation by upregulating BMP-2, and it exhibited a therapeutic effect in SAMP-6 mice, glucocorticoid-induced osteoporosis rats, and ovariectomized rats. In this study, aged C57 and SAMP-6 mice models were used to investigate the therapeutic and preventive effects of compound 125 on SOP. scRNA-seq analysis showed that BMP-2 upregulation is the mechanism through which 125 accelerates bone turnover and increases the proportion of osteoblasts. We evaluated the structure-activity relationship of the candidate drugs and found that the derivative I-9 showed significantly higher efficacy than 125 and teriparatide in the zebrafish osteoporosis model. This study provides a foundation for the development of SOP drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisBenzofuransRatsMiceAnimalsZebrafishOsteogenesisOsteoblastsStructure-Activity RelationshipPhenylmercury Compounds

Substanzen

Benzofurans4-(4-sulfophenylazo)-2-mercuriphenolPhenylmercury Compounds

Autor:innen und Institutionen

  • Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Zhuo-Rong Li

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences

Zitieren

APA

Zhou, Z. Y., Sun, L. Q., Han, X. Y., Wang, Y. J., Xie, Z. S., Xue, S. T., & Li, Z. R. (2023). Efficacy, Mechanism, and Structure–Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01377

Vancouver

Zhou ZY, Sun LQ, Han XY, Wang YJ, Xie ZS, Xue ST, et al. Efficacy, Mechanism, and Structure–Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01377

BibTeX
@article{Zhou2023,
  author = {Zhou, Zi-Ying and Sun, Lian-Qi and Han, Xiao-Yang and Wang, Yong-Jian and Xie, Zhuo-Song and Xue, Si-Tu and Li, Zhuo-Rong},
  title = {Efficacy, Mechanism, and Structure–Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01377}
}
Kostenlos starten →